# China NMPA Drug Inspection - Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. - Compound Scutellaria and Ligusticum Oral Solution

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/heilongjiang-zhenbaodao-pharmaceutical-co-ltd/5c76d4cc-47ae-4390-95d5-3f157600215b/
Source feed: China

> China NMPA drug inspection for Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. published October 19, 2018. Drug: Compound Scutellaria and Ligusticum Oral Solution. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Jiangxi Province 2018 No. 7 Drug Supervision and Sampling Inspection Information Announcement
- Company Name: Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
- Publication Date: 2018-10-19
- Drug Name: Compound Scutellaria and Ligusticum Oral Solution
- Inspection Finding: Compliant

Company: https://www.globalkeysolutions.net/companies/heilongjiang-zhenbaodao-pharmaceutical-co-ltd/0558350e-bc04-46cf-91cb-da7f3c9cee9a/